Skip to content

Clinical trials

Terminated Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: United Kingdom Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20042
20063
20072
20084
20091
20104
20113
20122
20132
20144
20156
20163
20175
20181
20194
20203
20214
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
European Organisation for Research and Treatment of Cancer - EORTC4
GlaxoSmithKline4
Hoffmann-La Roche4
Novartis Pharmaceuticals4
AstraZeneca2
Cambridge University Hospitals NHS Foundation Trust2
Cancer Research UK2
Imperial College London2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms59
Neoplasms7
Neoplasm Metastasis6
Ovarian Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms3
Small Cell Lung Carcinoma3
Brain Neoplasms2
Breast Neoplasms, Male2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.